Rigel Pharmaceuticals Company Profile (NASDAQ:RIGL)

About Rigel Pharmaceuticals

Rigel Pharmaceuticals logoRigel Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disorders. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. It has various product candidates in development: fostamatinib; R348; two oncology product candidates, and two preclinical programs. Fostamatinib is an oral spleen tyrosine kinase (SYK) inhibitor. R348 is a topical janus kinase (JAK)/SYK inhibitor. It is conducting research in the disease areas of inflammation/immunology and muscle wasting/muscle endurance.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: RIGL
  • CUSIP: 76655960
Key Metrics:
  • Previous Close: $2.61
  • 50 Day Moving Average: $2.55
  • 200 Day Moving Average: $2.44
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.58
  • P/E Growth: 0.00
  • Market Cap: $246.88M
  • Outstanding Shares: 94,589,000
  • Beta: 1.24
Additional Links:
Companies Related to Rigel Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Rigel Pharmaceuticals (NASDAQ:RIGL) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.60 (152.87% upside)

Analysts' Ratings History for Rigel Pharmaceuticals (NASDAQ:RIGL)
Show:
DateFirmActionRatingPrice TargetDetails
8/17/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
8/4/2016HC WainwrightReiterated RatingBuyView Rating Details
8/3/2016JPMorgan Chase & Co.Reiterated RatingBuy$5.00View Rating Details
8/1/2016BMO Capital MarketsInitiated CoverageOutperform$4.00View Rating Details
5/16/2016Jefferies GroupReiterated RatingBuy$10.00 -> $8.00View Rating Details
4/23/2016Credit Suisse Group AGUpgradeBuyView Rating Details
2/23/2015Wells Fargo & Co.Reiterated RatingHoldView Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Rigel Pharmaceuticals (NASDAQ:RIGL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
8/2/2016Q216($0.20)($0.15)$3.75 million$8.60 millionViewN/AView Earnings Details
5/3/2016Q116($0.19)($0.19)$4.00 million$5.03 millionViewListenView Earnings Details
3/8/2016Q415($0.14)($0.14)$8.90 million$8.50 millionViewListenView Earnings Details
11/3/2015Q315($0.17)($0.08)$5.00 million$12.90 millionViewListenView Earnings Details
8/4/2015Q215($0.22)($0.16)$2.67 million$5.18 millionViewListenView Earnings Details
5/7/2015Q414($0.18)($0.21)$16.00 million$2.18 millionViewListenView Earnings Details
3/3/2015Q4($0.27)($0.25)$2.50 million$8.25 millionViewN/AView Earnings Details
11/4/2014Q314($0.27)($0.24)ViewN/AView Earnings Details
8/5/2014Q214($0.25)($0.29)$1.05 millionViewN/AView Earnings Details
5/7/2014Q114($0.25)($0.25)$0.43 millionViewN/AView Earnings Details
3/4/2014Q4 13($0.25)($0.19)$5.80 millionViewN/AView Earnings Details
11/5/2013Q313($0.29)($0.27)$260.00 millionViewN/AView Earnings Details
8/6/2013Q2 2013($0.30)($0.26)$0.53 million$1.40 millionViewN/AView Earnings Details
5/7/2013Q1 2013($0.30)($0.29)$1.73 millionViewN/AView Earnings Details
3/5/2013Q4 2012($0.32)($0.30)ViewN/AView Earnings Details
11/6/2012Q312($0.38)($0.36)$0.84 millionViewN/AView Earnings Details
8/7/2012($0.34)($0.35)ViewN/AView Earnings Details
5/1/2012($0.33)($0.32)ViewN/AView Earnings Details
3/6/2012($0.28)($0.36)ViewN/AView Earnings Details
11/1/2011($0.28)($0.25)ViewN/AView Earnings Details
8/2/2011($0.36)($0.37)ViewN/AView Earnings Details
5/3/2011($0.36)($0.40)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Rigel Pharmaceuticals (NASDAQ:RIGL)
Current Year EPS Consensus Estimate: $-0.71 EPS
Next Year EPS Consensus Estimate: $-0.57 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.18)($0.18)($0.18)
Q3 20161($0.17)($0.17)($0.17)
Q4 20161$0.41$0.41$0.41
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Rigel Pharmaceuticals (NASDAQ:RIGL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Rigel Pharmaceuticals (NASDAQ:RIGL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/1/2015Donald G PayanEVPSell10,000$3.75$37,500.00View SEC Filing  
12/18/2014Dolly VanceEVPSell1,000$2.22$2,220.00View SEC Filing  
9/3/2014Donald G PayanEVPSell20,000$2.56$51,200.00View SEC Filing  
11/19/2013Bvf Partners P/Ilmajor shareholderSell484,622$2.64$1,279,402.08View SEC Filing  
6/7/2013Bvf Partners L P/IlMajor ShareholderBuy32,700$3.47$113,469.00View SEC Filing  
9/13/2012Dolly VanceEVPSell4,151$10.43$43,294.93View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Rigel Pharmaceuticals (NASDAQ:RIGL)
DateHeadline
News IconPenny Stock Under the Microscope: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Duncan Research (NASDAQ:RIGL)
www.duncanindependent.com - August 25 at 12:12 PM
marketexclusive.com logoWhat We’re Looking For From The Upcoming Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Data (NASDAQ:RIGL)
marketexclusive.com - August 23 at 11:38 AM
insidermonkey.com logoWhat We’re Looking For From The Upcoming Rigel Pharmaceuticals, Inc. (RIGL) Data (NASDAQ:RIGL)
www.insidermonkey.com - August 23 at 11:38 AM
investornewswire.com logoWill Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Hit $10 Price Target? - Investor Newswire (NASDAQ:RIGL)
www.investornewswire.com - August 20 at 6:46 PM
News IconPenny Stock Alert - Update & Review on This Stock: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Duncan Research (NASDAQ:RIGL)
www.duncanindependent.com - August 19 at 6:59 PM
capitalcube.com logoETF’s with exposure to Rigel Pharmaceuticals, Inc. : August 19, 2016 (NASDAQ:RIGL)
www.capitalcube.com - August 19 at 6:59 PM
News IconRigel Pharmaceuticals, Inc.'s (RIGL): Trader's Buzzer - Hot Stocks Point (NASDAQ:RIGL)
www.hotstockspoint.com - August 19 at 10:04 AM
News IconTaking A Closer Look at Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Duncan Research (NASDAQ:RIGL)
www.duncanindependent.com - August 17 at 7:31 PM
News IconTop Earnings to Watch for: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - The Voice Registrar (NASDAQ:RIGL)
voiceregistrar.com - August 17 at 7:31 PM
seekingalpha.com logoBinary event looming for Rigel Pharma investors - Seeking Alpha (NASDAQ:RIGL)
seekingalpha.com - August 17 at 7:31 PM
News IconA Closer Look at Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Duncan Research (NASDAQ:RIGL)
www.duncanindependent.com - August 16 at 7:15 PM
News IconNoteworthy Thursday Option Activity: RIGL, X, DIS (NASDAQ:RIGL)
www.stockoptionschannel.com - August 11 at 7:38 PM
finance.yahoo.com logoRIGEL PHARMACEUTICALS INC Financials (NASDAQ:RIGL)
finance.yahoo.com - August 9 at 7:25 PM
capitalcube.com logoETF’s with exposure to Rigel Pharmaceuticals, Inc. : August 8, 2016 (NASDAQ:RIGL)
www.capitalcube.com - August 8 at 7:22 PM
equities.com logoRigel Pharmaceuticals Inc. (RIGL) Jumps 5.48% on August 05 (NASDAQ:RIGL)
www.equities.com - August 5 at 7:23 PM
capitalcube.com logoRigel Pharmaceuticals, Inc. :RIGL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:RIGL)
www.capitalcube.com - August 5 at 7:23 PM
prnewswire.com logoRigel Announces Second Quarter 2016 Financial Results and Provides Portfolio Update (NASDAQ:RIGL)
www.prnewswire.com - August 4 at 7:38 PM
finance.yahoo.com logoEdited Transcript of RIGL earnings conference call or presentation 2-Aug-16 9:00pm GMT (NASDAQ:RIGL)
finance.yahoo.com - August 4 at 7:38 PM
fool.com logoWhy Rigel Pharmaceuticals Shares Soared 13.9% Today (NASDAQ:RIGL)
www.fool.com - August 3 at 6:03 PM
equities.com logoRigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for August 01 - Equities.com (NASDAQ:RIGL)
www.equities.com - August 3 at 10:25 AM
sg.finance.yahoo.com logoRigel reports 2Q loss (NASDAQ:RIGL)
sg.finance.yahoo.com - August 2 at 7:29 PM
seekingalpha.com logoRigel Pharmaceuticals beats by $0.05, beats on revenue (NASDAQ:RIGL)
seekingalpha.com - August 2 at 5:26 PM
streetupdates.com logoNotable Stocks within Analysts Radar: Endo International plc (NASDAQ:ENDP) , Rigel Pharmaceuticals, Inc. (NASDAQ ... - Street Updates (NASDAQ:RIGL)
www.streetupdates.com - August 2 at 12:05 PM
biz.yahoo.com logoQ2 2016 Rigel Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:RIGL)
biz.yahoo.com - August 2 at 12:05 PM
benzinga.com logoBMO Analysts Initiate Coverage On Rigel Pharma, Seeing 65% Upside (NASDAQ:RIGL)
www.benzinga.com - August 1 at 6:54 PM
fidaily.com logoBMO Capital Initiates Coverage on Rigel Pharmaceuticals, Inc. (RIGL) Setting A Rating Of “Outperform” (NASDAQ:RIGL)
www.fidaily.com - August 1 at 11:48 AM
live-pr.com logoRigel Pharmaceuticals, Inc. (RIGL) - Financial and Strategic SWOT Analysis Review - New Report Available (NASDAQ:RIGL)
www.live-pr.com - July 28 at 10:22 AM
publicnow.com logoRigel Announces Conference Call and Webcast to Report Second Quarter 2016 Financial Results (NASDAQ:RIGL)
www.publicnow.com - July 26 at 7:58 AM
investornewswire.com logoIs $10 Price Target Attainable For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)? - Investor Newswire (NASDAQ:RIGL)
www.investornewswire.com - July 23 at 6:35 PM
news.cmlviz.com logoOption Market: Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Risk Hits An Extreme High - CML News (NASDAQ:RIGL)
news.cmlviz.com - July 23 at 10:58 AM
equities.com logoRigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for July 21 - Equities.com (NASDAQ:RIGL)
www.equities.com - July 23 at 10:58 AM
news.cmlviz.com logoRigel Pharmaceuticals Inc Stock Technicals at Critical Inflection Point - CML News (NASDAQ:RIGL)
news.cmlviz.com - July 22 at 10:05 AM
streetupdates.com logoLatest Analysts Score of Stocks: Teva Pharmaceutical Industries Limited (NYSE:TEVA) , Rigel Pharmaceuticals, Inc ... - Street Updates (NASDAQ:RIGL)
www.streetupdates.com - July 22 at 10:05 AM
fiscalstandard.com logoRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Current Analyst Ratings - Fiscal Standard (NASDAQ:RIGL)
www.fiscalstandard.com - July 22 at 10:05 AM
News IconStock Moving Lower for the Month; Investor Update on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Engelwood Daily (NASDAQ:RIGL)
www.engelwooddaily.com - July 21 at 9:58 AM
seekingalpha.com logoWhy You Should Own Rigel Pharmaceuticals, Inc. - Seeking Alpha (NASDAQ:RIGL)
seekingalpha.com - July 19 at 8:06 AM
capitalcube.com logoETF’s with exposure to Rigel Pharmaceuticals, Inc. : July 18, 2016 (NASDAQ:RIGL)
www.capitalcube.com - July 18 at 2:14 PM
investornewswire.com logoStrong Sell Calls For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) At 0 - Investor Newswire (NASDAQ:RIGL)
www.investornewswire.com - July 18 at 12:40 PM
News IconWere Analysts Bullish Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) This Week? - Press Telegraph (NASDAQ:RIGL)
presstelegraph.com - July 16 at 6:36 PM
News IconShares Experiencing a Downtrend: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - TGP (NASDAQ:RIGL)
telanaganapress.com - July 16 at 10:23 AM
fiscalstandard.com logoBroker Outlook For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Fiscal Standard (NASDAQ:RIGL)
www.fiscalstandard.com - July 16 at 10:23 AM
news.cmlviz.com logoRigel Pharmaceuticals Inc Realized Volatility Hits an Inflection Level - CML News (NASDAQ:RIGL)
news.cmlviz.com - July 16 at 10:23 AM
News IconShare Volatility Watch for: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Engelwood Daily (NASDAQ:RIGL)
www.engelwooddaily.com - July 15 at 12:21 PM
News IconRigel Pharmaceuticals, Inc. Has Another Very Weak Trading Session - Consumer Eagle (NASDAQ:RIGL)
www.consumereagle.com - July 15 at 12:21 PM
seekingalpha.com logoThis Week In Pharma: What Can We Expect From Rigel's And Ultragenyx's Upcoming Phase 3 Results? (NASDAQ:RIGL)
seekingalpha.com - July 14 at 10:46 AM
feeds.benzinga.com logoSoaring +11% In Pre-Market, Rigel Receives Buy Initiation Amid Fostamatinib Phase 3 Optimism (NASDAQ:RIGL)
feeds.benzinga.com - July 13 at 10:15 AM
fidaily.com logoH.C. Wainwright Starts Coverage on Rigel Pharmaceuticals, Inc. (RIGL) With A Rating Of “Buy” (NASDAQ:RIGL)
www.fidaily.com - July 13 at 10:01 AM
news.cmlviz.com logoRigel Pharmaceuticals Inc Stock Momentum at Critical Inflection Point - CML News (NASDAQ:RIGL)
news.cmlviz.com - July 12 at 7:22 PM
News IconRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Sellers Covered 5.35% of Their Shorts - Consumer Eagle (NASDAQ:RIGL)
www.consumereagle.com - July 12 at 11:32 AM
finance.yahoo.com logoCoverage initiated on Rigel Pharma by Piper Jaffray (NASDAQ:RIGL)
finance.yahoo.com - June 13 at 6:44 AM

Social

Rigel Pharmaceuticals (NASDAQ:RIGL) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff